Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)

Document Type : Case Report


1 dr

2 Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran


Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) is a highly infectious viral syndrome currently threatening millions of people worldwide. It is widely recognized as a disease of the pulmonary system, presenting with fever, cough, and shortness of breath. However, a number of extra pulmonary manifestations have been described in the literature. SARS-CoV-2 is expressed in gastrointestinal (GI) epithelial cells suggesting that SARS-CoV-2 can infect and replicate in the GI tract. The most prevalent GI features of COVID-19 include abdominal pain, nausea, vomiting, and diarrhea. There is limited data regarding GI bleeding in patients with COVID-19.
Method: This single-centered, retrospective case series was conducted at Razi hospital in Khuzestan province southwestern Iran one of the provinces with highest prevalence and death due to COVID-19 disease. We recorded cases of SARS-CoV-2 infection and concurrent GI bleeding who went through surgery from September 22, 2020 to November 21, 2020. 500 patients where admitted into the this COVID-19 center of Ahvaz city in this time line. a reverse transcription polymerase chain reaction (RT-PCR) test was performed and SARS-CoV-2 RNA was detected in the nasopharyngeal swab for each of 2 patients.
Results: we had two different severities of bleeding and source associated with two different respiratory involvements. each of two patient showed a good respond too surgery and did not showed another episode of bleeding.
conclusion: in rifer to other studies and our different outcome and severity of our two patient GI bleeding in


1-Lisa F. Barrett, , Kevin Bryan Lo, Steven R. Stanek, James W. Walter, Self-limited: gastrointestinal bleeding in COVID-19, ClinicsandResearchinHepatologyandGastroenterology(2020)44,e77—e80
2-Roberto Penagini, Roberto  Frego,  Sandro Ardizzone Aurelio Mauro,  Federico De Grazia, Marco Vincenzo Lenti: Upper gastrointestinal bleeding in COVID-19 inpatients, Clinics and Research in Hepatology and Gastroenterology (2020) 42, e115--- e118
3-Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497–506
4-Monika Misak, Ali Pourmand, Marya AlSamman, Amy Caggiula, Sangrag Ganguli: Non-respiratory presentations of COVID-19, a clinical review, American Journal of Emergency Medicine (2020) – 159424; e11
5-Ajay Gandhi, Klaus Görlinger: Coagulopathy in COVID-19: Connecting the Dots Together, J Card Crit Care:2020;4:47–50
6-Taojiang Chen, Qin Yang, Hongyu Duan: A severe coronavirus disease 2019 patient with high-risk predisposing factors died from massive gastrointestinal bleeding: a case report, Chen et al. BMC Gastroenterology (2020) 20:318
7-Li-Bo Zhang, Rong-Rong Pang , Qing-Hua Qiao, Zhi-Hua Wang, Xin-Yi Xia, Chang-Jun Wang: Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma, Zhang et al. Military Medical Research (2020) 7:45
8-Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708 –20.
9-Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497 –506.
10-Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061 -9.